Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study
Hoffmann-La Roche
Ian E Krop; Seock-Ah Im; Carlos Barrios; Hervé Bonnefoi; Julie Gralow; Masakazu Toi; Paul A Ellis; Luca Gianni; Sandra M Swain; Young-Hyuck Im; Michelino De Laurentiis; Zbigniew Nowecki; Chiun-Sheng Huang; Louis Fehrenbacher; Yoshinori Ito; Jigna Shah; Thomas Boulet; Haiying Liu; Harrison Macharia; Peter Trask; Chunyan Song; Eric P Winer; Nadia Harbeck